About
MYCENAX is a CDMO that provides biopharmaceutical development and manufacturing services for biologics and biosimilars. It serves customers in Taiwan, Japan, Korea, Singapore, Europe, the United States, and other Asia-Pacific regions from sites in Taiwan.
Services
Manufacturability
Assesses product developability to support early biopharmaceutical development.
Cell Line Development
Develops cell lines for biologics production.
Cell line development
Upstream Process Development
Develops upstream manufacturing processes for biologics.
Downstream Process Development
Develops downstream purification processes for biologics.
Analytical Method Development
Develops and validates analytical methods for biopharmaceuticals.
Formulation Development
Develops formulations for biopharmaceutical products.
Technology Transfer
Transfers processes from development to manufacturing or between sites.
Drug Substance Manufacturing
Manufactures drug substance by mammalian cell culture and microbial culture processes.
CDMO: development & manufacturing
4 more services
- Aseptic Fill Finish
- Process Characterization (PC) and Process Validation (PV)
- Cell-based Assays
- Characterization Services
- Turnaround
- 3 weeks
- 7 months
- What to send
- 250 mL peripheral blood
- One leukopak
- One cord blood unit
Capabilities
- Assays and studies
- Antibodies
- LC-MS/MS
- ADCs
- Process development
- Cell-based assays
- HPLC
17 more
- SPR
- Analytical development
- Cell therapy
- Bispecifics
- LC-MS
- SEC-MALS
- SV-AUC
- DSC
- Dynamic light scattering
- Circular dichroism
- FT-IR spectroscopy
- HILIC-UPLC
- RP-HPLC
- ELISA
- CE-SDS
- cIEF/icIEF
- HCP
- Scale and capacity
- 25 L to 2,000 L
- 5 L to 2,000 L
- 2 GMP-compliant facilities
- 2 filling lines
- 2R, 4R, and 10R vials
- Liquid prefilled syringes (PFS) and cartridges
9 more
- Ambr250®
- 2 L
- 10 L
- 50 L
- 200 L
- G-Rex
- 50M
- 100M
- 500M
- Therapeutic areas
- Biopharmaceuticals
- Biosimilars
- Cell and gene therapy
Instruments and platforms
- SoloVPE
- Maurice systems
- Biacore
- LC-MS
- SEC-MALS
- SV-AUC
- DSC
- DLS
Modalities and species
- Modalities
- Antibody
- Bispecific
- ADC
- mRNA
- Cell therapy
- Recombinant protein
- Biosimilar
- Plasmid DNA
- Species and models
- Mammalian
- Microbial
- γδT
- NK
- PBNK
- CBNK
- K562
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Company
- Type
- CDMO
- Founded
- 2019
Locations
- Office
- 3 Road, Zhunan, Miaoli 350401, Taiwan GMP Plant 2 No. 8, Kexi 1st Rd., Zhuna
- Sites
- Zhubei City, Hsinchu County, Taiwan
- Zhunan, Miaoli, Taiwan
- Taipei City, Taiwan
- Serves
- Taiwan, Japan, Korea, Singapore, Asia-Pacific, Europe, United States
Contacts
- General enquiry
- info@mycenax.com on their site